Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Edwards Lifesciences Corporation (EW) had Normalized Pre-Tax Income of $1.55B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$5.44B |
|
$4.17B |
|
$1.12B |
|
$4.32B |
|
$4.06B |
|
$1.38B |
|
$169.40M |
|
$1.55B |
|
|
Normalized Pre-Tax Income |
$1.55B |
$1.40B |
|
$1.40B |
|
$4.17B |
|
$1.40B |
|
$1.38B |
|
$1.38B |
|
597.70M |
|
599.30M |
|
$6.98 |
|
$6.97 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|